| ²é¿´: 571 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë
|
|
| With respect to the treatment of metastatic disease, the magnitude and diversity of targets for antiangiogenic approaches suggest numerous possibilities for antiangiogenic drug combinations that should be much more effective than monotherapy in treating cancer. |
» ²ÂÄãϲ»¶
318Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
0703»¯Ñ§
ÒѾÓÐ13È˻ظ´
307·Ö²ÄÁÏרҵÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0855Çóµ÷¼Á²ÄÁÏ
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¼×´¼/¶þÂÈ 1:15¹ýÖù×Ó
ÒѾÓÐ3È˻ظ´
272Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸Î÷±±Å©ÁÖÐóÄÁר˶336·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´

8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- É¢½ð: 47
- ºì»¨: 16
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
- ×¢²á: 2011-01-06
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
3Â¥2012-09-27 08:42:41
nanbingyue
½ð³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1116.5
- É¢½ð: 568
- ºì»¨: 5
- Ìû×Ó: 667
- ÔÚÏß: 125.5Сʱ
- ³æºÅ: 2004188
- ×¢²á: 2012-09-16
- רҵ: È˸ñÐÄÀíѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ 2012-09-26 10:10:31
Carena: ½ð±Ò+2, ´ú·¢½ð±Ò£¬¸ÐлӦÖú 2012-11-26 14:49:22
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ 2012-09-26 10:10:31
Carena: ½ð±Ò+2, ´ú·¢½ð±Ò£¬¸ÐлӦÖú 2012-11-26 14:49:22
| Ëæ×ÅÈËÃǶ԰©Ö¢ÖÎÓúµÄÆÚ´ý£¬¿¹Ñª¹ÜÔöÉúµÄ¸÷Ö̶ֳÈ/µÈ¼¶ºÍ¶àÑùÐÔµÄ;¾¶¸øÈËÃÇÌṩÁ˶ÔÓÚ¿¹Ñª¹ÜÉú³ÉµÄÒ©Îï×éºÏ±Èµ¥Ò»ÖÎÁư©Ö¢µÄÁÆ·¨¸üÓÐЧµÄÊý²»ÇåµÄ¿ÉÄÜÐÔ¡£ |
2Â¥2012-09-25 22:32:21














»Ø¸´´ËÂ¥